USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	052615/0982			Pages:	17
		Recorded:	05/08/2020
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 45

Patent #:	7157569	Issue Dt:	01/02/2007	Application #:	10312184	Filing Dt:	04/09/2003
Publication #:	US20040038236	Pub Dt:	02/26/2004
Title:	MUTATION ASSOCIATED WITH EPILEPSY

Patent #:	7078515	Issue Dt:	07/18/2006	Application #:	10451126	Filing Dt:	10/08/2003
Publication #:	US20040110706	Pub Dt:	06/10/2004
Title:	SODIUM-CHANNEL ALPHA1-SUBUNIT AND THEIR POLYPEPTIDES AND THEIR TREATMENT OF GENERALISED EPILEPSY WITH FEBRILE SEIZURES PLUS

Patent #:	8129142	Issue Dt:	03/06/2012	Application #:	10567424	Filing Dt:	12/09/2008
Publication #:	US20090081724	Pub Dt:	03/26/2009
Title:	MUTATIONS IN ION CHANNELS

Patent #:	7709225	Issue Dt:	05/04/2010	Application #:	11262647	Filing Dt:	10/31/2005
Publication #:	US20060252121	Pub Dt:	11/09/2006
Title:	NUCLEIC ACIDS ENCODING MUTATIONS IN SODIUM CHANNELS RELATED TO EPILEPSY

Patent #:	7282336	Issue Dt:	10/16/2007	Application #:	11263326	Filing Dt:	10/31/2005
Publication #:	US20060089306	Pub Dt:	04/27/2006
Title:	METHOD OF DIAGNOSING EPILEPSY

Patent #:	7723037	Issue Dt:	05/25/2010	Application #:	11850897	Filing Dt:	09/06/2007
Publication #:	US20080182247	Pub Dt:	07/31/2008
Title:	METHODS AND KITS FOR DIAGNOSING OR MONITORING AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASE

Patent #:	8198466	Issue Dt:	06/12/2012	Application #:	12162917	Filing Dt:	05/28/2009
Publication #:	US20100004208	Pub Dt:	01/07/2010
Title:	SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS

Patent #:	8293737	Issue Dt:	10/23/2012	Application #:	12311872	Filing Dt:	11/23/2009
Publication #:	US20100105678	Pub Dt:	04/29/2010
Title:	NOVEL ANXIOLYTIC COMPOUNDS

Patent #:	8466163	Issue Dt:	06/18/2013	Application #:	12448146	Filing Dt:	10/13/2009
Publication #:	US20100048591	Pub Dt:	02/25/2010
Title:	FURO[2,3-D]PYRIMIDINES AND RELATED COMPOUNDS AND METHODS FOR TREATING DISEASE STATES BY INHIBITING TUBULIN POLYMERIZATION

Patent #:	8309351	Issue Dt:	11/13/2012	Application #:	12681311	Filing Dt:	06/24/2010
Publication #:	US20100285497	Pub Dt:	11/11/2010
Title:	METHODS OF IDENTIFYING AGENTS THAT INHIBIT ANGIOGENESIS

Patent #:	7989182	Issue Dt:	08/02/2011	Application #:	12696769	Filing Dt:	01/29/2010
Publication #:	US20100136623	Pub Dt:	06/03/2010
Title:	NUCLEIC ACID ENCODING SCN1A VARIANT

Patent #:	8288096	Issue Dt:	10/16/2012	Application #:	12767523	Filing Dt:	04/26/2010
Publication #:	US20100203548	Pub Dt:	08/12/2010
Title:	DIAGNOSTIC METHOD FOR EPILEPSY

Patent #:	8507539	Issue Dt:	08/13/2013	Application #:	12997864	Filing Dt:	03/18/2011
Publication #:	US20110166130	Pub Dt:	07/07/2011
Title:	NOVEL POTASSIUM CHANNEL BLOCKERS AND USES THEREOF

Patent #:	9006284	Issue Dt:	04/14/2015	Application #:	13392473	Filing Dt:	02/24/2012
Publication #:	US20120149665	Pub Dt:	06/14/2012
Title:	COMBINATION THERAPY FOR TREATING PROLIFERATIVE DISEASES

Patent #:	8716335	Issue Dt:	05/06/2014	Application #:	13461213	Filing Dt:	05/01/2012
Publication #:	US20120214770	Pub Dt:	08/23/2012
Title:	SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS

Patent #:	8557982	Issue Dt:	10/15/2013	Application #:	13584046	Filing Dt:	08/13/2012
Publication #:	US20120309768	Pub Dt:	12/06/2012
Title:	NOVEL TUBULIN POLYMERISATION INHIBITORS

Patent #:	8551990	Issue Dt:	10/08/2013	Application #:	13617153	Filing Dt:	09/14/2012
Publication #:	US20130012508	Pub Dt:	01/10/2013
Title:	NOVEL ANXIOLYTIC COMPOUNDS

Patent #:	8614212	Issue Dt:	12/24/2013	Application #:	13617317	Filing Dt:	09/14/2012
Publication #:	US20130012509	Pub Dt:	01/10/2013
Title:	NOVEL ANXIOLYTIC COMPOUNDS

Patent #:	8680135	Issue Dt:	03/25/2014	Application #:	13657160	Filing Dt:	10/22/2012
Publication #:	US20130053351	Pub Dt:	02/28/2013
Title:	SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS

Patent #:	8674119	Issue Dt:	03/18/2014	Application #:	13810364	Filing Dt:	03/07/2013
Publication #:	US20130211102	Pub Dt:	08/15/2013
Title:	CHEMICAL PROCESSES FOR THE MANUFACTURE OF SUBSTITUTED BENZOFURANS

Patent #:	NONE	Issue Dt:		Application #:	14002536	Filing Dt:	11/05/2013
Publication #:	US20140051701	Pub Dt:	02/20/2014
Title:	METHODS OF TREATING A DISEASE OR CONDITION OF THE CENTRAL NERVOUS SYSTEM

Patent #:	8906912	Issue Dt:	12/09/2014	Application #:	14030808	Filing Dt:	09/18/2013
Publication #:	US20140045839	Pub Dt:	02/13/2014
Title:	NOVEL ANXIOLYTIC COMPOUNDS

Patent #:	9133188	Issue Dt:	09/15/2015	Application #:	14116196	Filing Dt:	01/15/2014
Publication #:	US20140128600	Pub Dt:	05/08/2014
Title:	METHODS FOR PREPARING NAPHTHYRIDINES

Patent #:	9346842	Issue Dt:	05/24/2016	Application #:	14183908	Filing Dt:	02/19/2014
Publication #:	US20140171642	Pub Dt:	06/19/2014
Title:	SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS

Patent #:	NONE	Issue Dt:		Application #:	14404782	Filing Dt:	12/01/2014
Publication #:	US20150133401	Pub Dt:	05/14/2015
Title:	COMBINATION THERAPY INVOLVING A VASCULAR DISRUPTING AGENT AND AN AGENT WHICH TARGETS HYPOXIA

Patent #:	9573945	Issue Dt:	02/21/2017	Application #:	14533808	Filing Dt:	11/05/2014
Publication #:	US20150166534	Pub Dt:	06/18/2015
Title:	NOVEL ANXIOLYTIC COMPOUNDS

Patent #:	9758516	Issue Dt:	09/12/2017	Application #:	14776595	Filing Dt:	09/14/2015
Publication #:	US20160039810	Pub Dt:	02/11/2016
Title:	A CRYSTALLINE FORM OF AN ANXIOLYTIC COMPOUND

Patent #:	9745296	Issue Dt:	08/29/2017	Application #:	14776643	Filing Dt:	09/14/2015
Publication #:	US20160185770	Pub Dt:	06/30/2016
Title:	SALTS, CO-CRYSTALS, AND POLYMORPHS OF AN ANXIOLYTIC COMPOUND

Patent #:	10213409	Issue Dt:	02/26/2019	Application #:	15141170	Filing Dt:	04/28/2016
Publication #:	US20170020840	Pub Dt:	01/26/2017
Title:	SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS

Patent #:	9987293	Issue Dt:	06/05/2018	Application #:	15301522	Filing Dt:	10/03/2016
Publication #:	US20170112862	Pub Dt:	04/27/2017
Title:	METHOD FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA

Patent #:	NONE	Issue Dt:		Application #:	15315025	Filing Dt:	11/30/2016
Publication #:	US20170119727	Pub Dt:	05/04/2017
Title:	A THERAPEUTIC PROTOCOL FOR TREATING OVARIAN CANCER

Patent #:	10159659	Issue Dt:	12/25/2018	Application #:	15322647	Filing Dt:	12/28/2016
Publication #:	US20170135980	Pub Dt:	05/18/2017
Title:	PREDICTING RESPONSE TO CANCER THERAPY

Patent #:	10564162	Issue Dt:	02/18/2020	Application #:	15322845	Filing Dt:	12/29/2016
Publication #:	US20180196048	Pub Dt:	07/12/2018
Title:	PREDICTIVE BIOMARKERS

Patent #:	10520508	Issue Dt:	12/31/2019	Application #:	15323151	Filing Dt:	12/30/2016
Publication #:	US20180196056	Pub Dt:	07/12/2018
Title:	PREDICTIVE BASELINE BIOMARKERS FOR USE OF VASCULAR DISRUPTING AGENTS

Patent #:	9914702	Issue Dt:	03/13/2018	Application #:	15366513	Filing Dt:	12/01/2016
Publication #:	US20170088519	Pub Dt:	03/30/2017
Title:	AMINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERS

Patent #:	9975892	Issue Dt:	05/22/2018	Application #:	15398472	Filing Dt:	01/04/2017
Publication #:	US20170183347	Pub Dt:	06/29/2017
Title:	NOVEL ANXIOLYTIC COMPOUNDS

Patent #:	10137105	Issue Dt:	11/27/2018	Application #:	15554917	Filing Dt:	08/31/2017
Publication #:	US20180042887	Pub Dt:	02/15/2018
Title:	COMBINATION TREATMENT PROTOCOL

Patent #:	10266529	Issue Dt:	04/23/2019	Application #:	15687274	Filing Dt:	08/25/2017
Publication #:	US20170362230	Pub Dt:	12/21/2017
Title:	SALTS, CO-CRYSTALS, AND POLYMORPHS OF AN ANXIOLYTIC COMPOUND

Patent #:	NONE	Issue Dt:		Application #:	15735505	Filing Dt:	12/11/2017
Publication #:	US20180161302	Pub Dt:	06/14/2018
Title:	PHARMACEUTICAL COMBINATION AND USES THEREOF

Patent #:	10954231	Issue Dt:	03/23/2021	Application #:	15844264	Filing Dt:	12/15/2017
Publication #:	US20180105523	Pub Dt:	04/19/2018
Title:	NOVEL ANXIOLYTIC COMPOUNDS

Patent #:	10233181	Issue Dt:	03/19/2019	Application #:	15844295	Filing Dt:	12/15/2017
Publication #:	US20180105524	Pub Dt:	04/19/2018
Title:	NOVEL ANXIOLYTIC COMPOUNDS

Patent #:	10745487	Issue Dt:	08/18/2020	Application #:	16086537	Filing Dt:	09/19/2018
Publication #:	US20190100600	Pub Dt:	04/04/2019
Title:	METHOD OF TREATING CANCER BY ADMINISTERING AN ANTI-LGR5 MONOCLONAL ANTIBODY

Patent #:	11655304	Issue Dt:	05/23/2023	Application #:	16333065	Filing Dt:	03/13/2019
Publication #:	US20190263925	Pub Dt:	08/29/2019
Title:	ANTIBODY AND CHECKPOINT INHIBITOR COMBINATION THERAPY

Patent #:	NONE	Issue Dt:		Application #:	16679193	Filing Dt:	11/09/2019
Publication #:	US20200069729	Pub Dt:	03/05/2020
Title:	Combination Therapy for Treating Proliferative Diseases

Patent #:	11478445	Issue Dt:	10/25/2022	Application #:	16758787	Filing Dt:	04/23/2020
Publication #:	US20210177797	Pub Dt:	06/17/2021
Title:	METHOD FOR TREATING ACUTE MYELOID LEUKEMIA

Assignor

BIONOMICS LTD

Exec Dt:

04/30/2020

Assignee

OXFORD FINANCE LLC, AS COLLATERAL AGENT

133 NORTH FAIRFAX STREET

ALEXANDRIA, VIRGINIA 22314

Correspondence name and address
	DLA PIPER LLP (US)
	401 B STREET, SUITE 1700
	SAN DIEGO, CA 92101

Search Results as of: 04/19/2024 09:48 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6